Generation Historical Income Statement
| GBIO Stock | USD 1.52 0.09 6.29% |
Historical analysis of Generation Bio income statement accounts such as Depreciation And Amortization of 3.8 M or Interest Expense of 12.5 M can show how well Generation Bio Co performed in making a profits. Evaluating Generation Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Generation Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Generation Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Generation Bio is a good buy for the upcoming year.
Generation |
About Generation Income Statement Analysis
Generation Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Generation Bio shareholders. The income statement also shows Generation investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Generation Bio Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Generation Bio. It is also known as Generation Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Generation Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Generation Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Generation Bio's Cost Of Revenue is very stable compared to the past year. As of the 29th of November 2024, Non Operating Income Net Other is likely to grow to about 5.5 M, while Depreciation And Amortization is likely to drop about 3.8 M.
| 2023 | 2024 (projected) | Depreciation And Amortization | 5.3M | 3.8M | Interest Income | 12.0M | 12.5M |
Generation Bio income statement Correlations
Click cells to compare fundamentals
Generation Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Generation Bio income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | 985K | 591K | (50K) | 4.5M | 12.0M | 12.5M | |
| Depreciation And Amortization | 1.9M | 3.4M | 4.5M | 5.1M | 5.3M | 3.8M | |
| Selling General Administrative | 12.2M | 22.6M | 33.9M | 44.5M | 50.9M | 31.7M | |
| Gross Profit | (1.9M) | (3.4M) | (4.5M) | (5.1M) | (73.9M) | (70.2M) | |
| Other Operating Expenses | 62.3M | 81.1M | 119.1M | 141.2M | 144.5M | 107.3M | |
| Operating Income | (62.3M) | (81.1M) | (119.1M) | (141.2M) | (138.6M) | (145.5M) | |
| Net Income From Continuing Ops | (61.3M) | (80.5M) | (119.2M) | (136.6M) | (126.6M) | (132.9M) | |
| Ebit | (62.3M) | (81.1M) | (119.1M) | (141.2M) | (138.6M) | (145.5M) | |
| Research Development | 50.1M | 58.5M | 85.2M | 96.7M | 93.6M | 75.6M | |
| Ebitda | (60.4M) | (77.7M) | (114.6M) | (136.1M) | (133.3M) | (140.0M) | |
| Total Operating Expenses | 62.3M | 81.1M | 119.1M | 141.2M | 144.5M | 107.3M | |
| Reconciled Depreciation | 1.9M | 3.4M | 4.5M | 5.1M | 5.3M | 3.8M | |
| Income Before Tax | (61.3M) | (80.5M) | (119.2M) | (136.6M) | (126.6M) | (132.9M) | |
| Total Other Income Expense Net | 985K | 591K | (50K) | 4.5M | 12.0M | 12.5M | |
| Net Income Applicable To Common Shares | (61.3M) | (80.5M) | (119.2M) | (136.6M) | (123.0M) | (129.1M) | |
| Net Income | (60.3M) | (76.5M) | (114.7M) | (132.1M) | (126.6M) | (132.9M) | |
| Income Tax Expense | (985K) | (4.0M) | (4.5M) | (4.5M) | 5.1M | 5.3M |
Pair Trading with Generation Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.Moving against Generation Stock
| 0.8 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.75 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.73 | VTRS | Viatris | PairCorr |
| 0.51 | GILD | Gilead Sciences | PairCorr |
| 0.46 | WAT | Waters | PairCorr |
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.28 | Quarterly Revenue Growth 2.52 | Return On Assets (0.19) | Return On Equity (0.86) |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.